Skip to main content
. 2014 Nov 2;17(4Suppl 3):19537. doi: 10.7448/IAS.17.4.19537

Figure 2.

Figure 2

Comparison of persistence on ARV regimens among patients treated with EVG/COBI/TDF/FTC, RPV/TDF/FTC, EFV/TDF/FTC and MTR (after EVG/COBI/TDF/FTC became available on August 27, 2012).